ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes - Report - MDSpire

ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes

  • By

  • Shaoqing Yin

  • Jiaye Li

  • Wei Zhang

  • Rui Ding

  • Yan Li

  • Kai Wang

  • Wenjian Jiang

  • Yi-Da Tang

  • Zhengjun Yi

  • Yaohua Zhang

  • Meng Li

  • June 17, 2026

  • 0 min

Share

Clinical Report: Genetic Variations in the ABO Gene and Disease Risk

Overview

The ABO gene influences disease susceptibility and drug response, with non-O blood groups linked to higher cancer and cardiovascular disease risks.

Background

The ABO blood group system is a genetic polymorphism that affects various physiological and pathological processes.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • Non-O blood groups are associated with increased risks of gastric, pancreatic, ovarian, and bladder cancers.
  • Individuals with non-O blood types have higher concentrations of von Willebrand factor (vWF).
  • Group O individuals are more susceptible to gastrointestinal infections.
  • Functional variations in ABO glycosyltransferases can modulate drug efficacy.
  • Elevated plasma BGAT levels are linked to increased venous thromboembolism risk.

Clinical Implications

Healthcare professionals should consider ABO blood type when assessing disease risk and tailoring treatment plans. Understanding the genetic basis of drug response can enhance personalized medicine approaches in clinical practice.

Conclusion

The ABO gene plays a pivotal role in disease susceptibility and treatment responses, highlighting the need for further research in personalized healthcare strategies.

Related Resources & Content

  1. Impact of rs2032582 Variant in ATP Binding Cassette Subfamily B Member 1 on Inflammatory Bowel Disease Risk: A Comprehensive Meta-Analysis Involving 14,876 Participants
  2. Can a Genetic Variant Affect the Efficacy of Abiraterone?
  3. Is Assessing Gene Polymorphisms Useful for Personalizing Treatment in HSCT Patients?
  4. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease - PubMed
  5. Association Between ABO Blood Type and Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis
  6. Association between ABO blood groups and pancreatic cancer outcomes: A systematic review and meta-analysis
  7. Blood Cancer Journal — Cytogenetic Variations in AL Amyloidosis Between African American and Caucasian Populations
  8. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease - PubMed
  9. Association Between ABO Blood Type and Risk of Pulmonary Embolism: A Systematic Review and Meta-Analysis - PMC
  10. Association between ABO blood groups and pancreatic cancer outcomes: A systematic review and meta-analysis - ScienceDirect

Original Source(s)

ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes

  • by Shaoqing Yin, Jiaye Li, Wei Zhang, Rui Ding, Yan Li, Kai Wang, Wenjian Jiang, Yi-Da Tang, Zhengjun Yi, Yaohua Zhang, Meng Li

  • June 17, 2026

Related Content

Case Report: Alectinib and CNS-directed therapy for primary or relapsed ALK-positive anaplastic large cell lymphoma with central nervous system involvement

Baseline 18F-FDG PET/CT habitat radiomics versus dual-channel deep learning for predicting interim PET early metabolic response in diffuse large B-cell lymphoma: a comparative study

D-VRD induction and autologous transplant in patients ≥70 years